Close

Guidance for GoodRx Holdings, Inc. (GDRX)

Period Range Estimate Revenue Range Revenue Estimate Target Details
2024 N/A N/A $800.00M $795.20M = Maintained Details
Q1 2024 N/A N/A $195.00M – 198.00M $194.80M = Maintained Details
2023 N/A N/A $750.00M – 775.00M $784.00M = Maintained Details
2023 N/A N/A $742.00M – 748.00M $754.90M = Maintained Details
Q4 2023 N/A N/A $188.00M – 194.00M $192.70M = Maintained Details
Q2 2023 N/A N/A $185.00M – 188.00M $191.70M = Maintained Details
Q4 2022 N/A N/A $173.00M – 180.00M $204.24M Lowered Details
Q3 2022 N/A N/A $185.00M $201.00M Lowered Details
Q2 2022 N/A N/A $190.00M $215.60M Lowered Details
Q1 2022 N/A N/A $200.00M $227.92M Lowered Details
2021 N/A N/A $735.00M – 755.00M $737.60M = Maintained Details
2021 N/A N/A $740.00M – 760.00M $748.40M = Maintained Details
Q4 2021 N/A N/A $212.00M – 222.00M $217.00M = Maintained Details
Q2 2021 N/A N/A $172.00M – 176.00M $172.40M = Maintained Details
Q1 2021 N/A N/A $158.00M – 161.00M $162.00M = Maintained Details
Q4 2020 N/A N/A $148.00M $144.00M = Maintained Details